IMPACT OF CLINICAL PHARMACIST MEDIATED PATIENT COUNSELING IN DYS-LIPIDEMIA PATIENTS BY USING LIPID LOWERING AGENTS

Aim: To estimate the impact of clinical pharmacist mediated patient counseling in dyslipidemia patients in RIMS hospital, Kadapa. Objectives: To conduct a randomized study on patients. To categorize patients on demographic basis, comorbidities. To compare the lipid levels based on 20 mg and 40 mg doses of atorvastatin, the outcome based on lipid profile. Methodology: It is a prospective observational, comparative type of study. Conducted in the department of general medicine, Rajiv Gandhi institute of medical sciences at Kadapa with a period of Six months (July 2018 to December 2018), and the sample size was 72 subjects. Results: A total of 72 patients were included in the study 86.11% were male, and 13.88% were female. Average age was found to be 57.11 years. Average BMI of males is 25.4 and females is 27.17 .36 patients included in group A (statin therapy) and 36 patients included in group B (statin + patient counseling). The P value of lipid levels in group A, and group B with two different doses of atorvastatin was found to be 0.7439. Baseline average lipids of both groups compared with fallow up final average lipid levels, and the P-value was found to be 0.2427. Conclusion: The findings in our study conclude that males are having a high risk of dyslipidemia, commonly obtained comorbidity is HTN, and there is no significant difference between the patients of group A and B.